Zogenix Inc (NASDAQ:ZGNX)
During the Trading Day
| 1.51 |  -0.01 / -0.66% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 1.51 |  0.00 / 0.00% |
Volume: 5.7K |
Latest ZGNX News | Press Releases
No recent news for Zogenix Inc.
Today’s Trading
| Previous close | 1.52 |
| Today’s open | 1.53 |
| Day’s range | 1.50 - 1.55 |
| Volume | 414,635 |
| Average volume (3 months) | 1,188,955 |
| Market cap | $153.2M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +69.90% |
| Earnings growth (this year) | +17.78% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +17.96% |
| P/E ratio | NM |
| Price/Sales | 2.42 |
| Price/Book | 10.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OGXIOncoGenex Pharmaceut... | -0.28 | -2.68% |
| APDNApplied DNA Sciences... | -0.00 | -1.11% |
| POZNPOZEN Inc | -0.06 | -1.21% |
| AVEOAveo Pharmaceuticals... | -0.24 | -8.28% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 14, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $44.3M |
| Annual profit (last year) | -$47.4M |
| Net profit margin | -106.90% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman Cam L. Garner, MBA |
President & Director Stephen J. Farr, PhD |
Corporate headquarters San Diego, California |
Forecasts
